StockData
Soligenix, Inc. logo

Soligenix, Inc. (SNGX) stock

SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.25−0.03 (-9.88%)

Close on Nov 18, 2026Market cap $5.50MP/E –Yield –

Soligenix market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Soligenix's market cap was $6.95M on Nov 11, 2026, against $15.68M a year earlier. Over the last 5 years it ranged from $1.70M to $37.80M, with a median of $7.57M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$6.95M-47.4%
2025Dec 31, 2025$13.21M+113.6%
2024Dec 31, 2024$6.19M-21.3%
2023Dec 29, 2023$7.86M-59.5%
2022Dec 30, 2022$19.40M-31.1%
2021Dec 31, 2021$28.15M-26.3%
2020Dec 31, 2020$38.20M+44.9%
2019Dec 31, 2019$26.37M+73.4%
2018Dec 31, 2018$15.21M+15.7%
2017Dec 29, 2017$13.15M+55.6%
2016Dec 30, 2016$8.45M-72.4%
2015Dec 31, 2015$30.59M+41.5%
2014Dec 31, 2014$21.61M-37.3%
2013Dec 31, 2013$34.47M+414.8%
2012Dec 31, 2012$6.70M-94.9%
2011Dec 30, 2011$132.59M–

More Soligenix figures

See a number that looks wrong?